- Newsroom
- Here
News
Element Biosciences Launches Trinity™ – A Revolutionary Targeted Sequencing Innovation to Streamline Genomic Research
Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth
Element Biosciences Fortifies its Executive Team with Experts in Artificial Intelligence and Product Development
Element Biosciences Announces Record Sequencer Installation Growth Ahead of Participation in Investor Conferences